ATNM stock icon

Actinium Pharmaceuticals
ATNM

$1.78
3.49%

Market Cap: $55.5M

 

About: Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Employees: 49

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

70% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $629K

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

11% more funds holding

Funds holding: 65 [Q1] → 72 (+7) [Q2]

1% more capital invested

Capital invested by funds: $52.6M [Q1] → $53M (+$332K) [Q2]

0.19% less ownership

Funds ownership: 24.23% [Q1] → 24.03% (-0.19%) [Q2]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4
125%
upside
Avg. target
$27
1,431%
upside
High target
$50
2,709%
upside

4 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Joseph Pantginis
31% 1-year accuracy
85 / 271 met price target
125%upside
$4
Buy
Maintained
6 Aug 2024
Maxim Group
Jason McCarthy
25% 1-year accuracy
5 / 20 met price target
181%upside
$5
Buy
Maintained
6 Aug 2024
HC Wainwright & Co.
Joseph Pantginis
31% 1-year accuracy
85 / 271 met price target
2,709%upside
$50
Buy
Reiterated
26 Jul 2024
HC Wainwright & Co.
Joseph Pantginis
31% 1-year accuracy
85 / 271 met price target
2,709%upside
$50
Buy
Reiterated
17 Jun 2024

Financial journalist opinion

Based on 66 articles about ATNM published over the past 30 days